| ASSET | YEAR | % RETURN |
|---|---|---|
Genmab A-S (GMAB) | 2010 | -19.16% |
Genmab A-S (GMAB) | 2011 | -51.56% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Genmab A-S (GMAB) | 2013 | 179.57% |
Genmab A-S (GMAB) | 2014 | 46.06% |
Genmab A-S (GMAB) | 2015 | 123.37% |
Genmab A-S (GMAB) | 2016 | 23.29% |
Genmab A-S (GMAB) | 2017 | -1.35% |
Genmab A-S (GMAB) | 2018 | -3.36% |
Genmab A-S (GMAB) | 2019 | 43.88% |
Genmab A-S (GMAB) | 2020 | 80.79% |
Genmab A-S (GMAB) | 2021 | -2.87% |
Genmab A-S (GMAB) | 2022 | 6.43% |
Genmab A-S (GMAB) | 2023 | -25.94% |
Genmab A-S (GMAB) | 2024 | -33.43% |
Genmab A-S (GMAB) | 2025 | 48.18% |
